Modifications in brain cAMP- and calcium/calmodulin-dependent protein kinases induced by treatment with S-adenosylmethionine

Neuropharmacology

Volumn 37, Issue 8, 1998, Pages 1081-1089

  Zanotti, S ^a,b   Mori, S ^a   Radaelli, R ^a   Perez, J ^c   Racagni, G ^a   Popoli, M ^a,d  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antidepressant; Neurotransmitter release; Protein phosphorylation; S adenosylmethionine; Signal transduction; Synapsin I

Indexed keywords

CYCLIC AMP; PROTEIN KINASE; S ADENOSYLMETHIONINE; SYNAPSIN I;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CEREBRAL CORTEX; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HIPPOCAMPUS; MALE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; S-ADENOSYLMETHIONINE; SIGNAL TRANSDUCTION; SYNAPSINS; SYNAPTIC VESICLES;

EID: 0031665765     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00088-4     Document Type: Article

References (38)

1. Bel, N., Artigas, F., 1993. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15, 243-245.
2. Blier, P., Bouchard, C., 1994. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. Br. J. Pharmacol. 113, 485-495.
3. Blier, P., de Montigny, C., 1994. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15, 220-225.
4. Bottiglieri, T., 1997. Ademetionine (S-adenosylmethionine) neuropharmacology: implications for drug therapies in psychiatric and neurological disorders. Exp. Opin. Invest. Drugs 6, 1-10.
5. Bottiglieri, T., Hyland, K., 1996. Effect of S-adenosylmethionine on dopamine metabolism in the rat striatum: an in vivo microdialysis study. Soc. Neurosci. Abs. 2, 834.
6. Bressa, G.M., 1994. S-adenosyl-L-methionine (SAMe) as antidepressant: meta-analysis of clinical studies. Acta Neurol. Scand. Suppl. 89, 7-14.
7. Chen, J., Rasenick, M.M., 1995. Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. J. Pharmacol. Exp. Ther. 275, 509-517.
8. Churn, S.B., Taft, W.C., Billingsley, M.S., Sankaran, B., De Lorenzo, R.J., 1992. Global forebrain ischemia induces a post-translational modification of multifunctional calcium- and calmodulin-dependent kinase II. J. Neurochem. 59, 1221-1232.
9. Edelman, A.M., Blumental, D.K., Krebs, E.G., 1987. Protein serine-threonine kinases. Ann. Rev. Biochem. 56, 567-613.
10. Friedel, H.A., Goa, K.L., Benfield, P., 1989. S-adenosyl-L-methionine: a review of its therapeutic potential in liver disfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 38, 389-416.
11. Greengard, P., Valtorta, F., Czernik, A.J., Benfenati, F., 1993. Synaptic vesicle phosphoproteins and regulation of synaptic function. Science 259, 780-785.
12. Hyman, S.E., Nestler, E.J., 1996. Initiation and adaptation: a paradigm for understanding psychotropic drug action. Am. J. Psychiatry. 153, 151-162.
13. Janicak, P.G., Lipinski, J.D., Comaty, J.E., Waternaux, C., Cohen, B., Altaman, E., Sharma, R.P., 1988. S-adenosylmethionine: a literature review and preliminary report. Alabama J. Med. Sci. 25, 306-313.
14. Lin, J.W., Sugimori, M., LLinas, R., McGuinness, T.L., Greengard, P., 1990. Effects of synapsin I and calcium-calmodulin-dependent protein kinase II on spontaneous neurotransmitter release in the squid giant synapse. Proc. Natl. Acad. Sci. USA 87, 8257-8261.
15. Mishima, K., Higuchi, H., Kamata, M., Yoshimoto, M., Hishikawa, Y., 1994. Effect of acute and chronic S-adenosylmethionine (SAM) administration on dopaminergic function in rat striatum. Proceedings of the 15th JSBP, p. 714.
16. Mochly Rosen, D., 1995. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268, 247-251.
17. Mudd, S.H., Cantoni, G.L., 1964. Biological transmethylation methyl group neogenesis and other 'one carbon metabolic reaction dependent upon tetrahydrofolic acid'. In: Florkin, M., Stotz, E.H. (Eds.), Comprehensive Biochemistry, vol. 15, pp. 1-47.
18. Nestler, E.J., Terwilliger, R.Z., Duman, R.S., 1989. Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. J. Neurochem. 53, 1644-1647.
19. Nibuya, M., Morinobu, S., Duman, R.S., 1995. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15, 7539-7547.
20. Nibuya, M., Nestler, E.J., Duman, R.S., 1996. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16, 2365-2372.
21. Nichols, R.A., Sihra, T.S., Czernik, A.J., Nairn, A.C., Greengard, P., 1990. Calcium-calmodulin-dependent protein kinase II increases glutamate and noradrenaline release from synaptosomes. Nature 343, 647-651.
22. Nomikos, G.G., Dansma, G., Wenkstern, D., Fibiger, H.C., 1991. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens. Eur. J. Pharmacol. 195, 63-73.
23. 2+/calmodulin-dependent kinase in intact hippocampal slices. Neuron 6, 907-914.
24. Perez, J., Tinelli, D., Brunello, N., Racagni, G., 1989. cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. Eur. J. Pharmacol. 172, 305-316.
25. Perez, J., Tinelli, D., Bianchi, E., Brunello, N., Racagni, G., 1991. cAMP binding proteins in the rat cerebral cortex after administration of selective 5-HT and NE reuptake blockers with antidepressant activity. Neuropsychopharmacology 4, 57-64.
26. Perez, J., Mori, S., Caivano, M., Popoli, M., Zanardi, R., Smeraldi, E., Racagni, G., 1995. Effects of fluvoxamine on the protein phosphorylation system associated with rat neuronal microtubules. Eur. Neuropsychopharmacol. Suppl. 65-69.
27. Popoli, M., 1993a. p65-synaptotagmin: a docking-fusion protein in synaptic vesicle exocytosis? Neuroscience 54, 323-328.
28. 2+/calmodulin protein kinase II in synaptic vesicles. FEBS Lett. 317, 85-88.
29. 2+/calmodulin-dependent protein kinase II: autophosphorylation and activity increase in the hippocampus after long-term blockade of serotonin reuptake. Mol. Pharmacol. 48, 623-629.
30. Popoli, M., Venegoni, A., Vocaturo, C., Buffa, L., Perez, J., Smeraldi, E., Racagni, G., 1997a. Synaptotagmin phosphorylation is affected by long-term blockade of 5-HT reuptake. Mol. Pharmacol. 51, 19-26.
31. 2+/phospholipid binding and syntaxin binding of native synaptotagmin. Life Sci. 61, 711-721.
32. Racagni, G., Brunello, N., Tinelli, D., Perez, J., 1992. New biochemical hypotheses on the mechanism of action of antidepressant drugs: cAMP-dependent phosphorylation system. Pharmacopsychiatry 25, 51-55.
33. Racagni, G., Popoli, M., Mori, S., Brunello, N., Perez, J., 1996. Targeting the action of antidepressant drugs on second-messenger systems. In: Ackeneil, M., Bondy, B., Engel, R., Ermann, M., Nedopil, N. (Eds.), Implications of Psychopharmacology to Psychiatry. Springer, New York, pp. 34-40.
34. Rosin, D.L., Melia, K., Knorr, A.M., Nestler, E.J., Roth, R.H., Duman, R.S., 1995. Chronic imipramine administration alters the activity and phosphorylation state of tyrosine hydroxylase in dopaminergic regions of rat brain. Neuropsychopharmacology 12, 113-121.
35. Spillmann, M., Fava, M., 1996. S-adenosylmethionine in psychiatric disorders - historical perspective and current aspects. CNS Drugs 6, 416-425.
36. Therkauf, W.E., Vallee, R.B., 1983. Extensive cAMP-dependent and cAMP-independent phosphorylation of microtubule-associated protein 2. J. Biol. Chem. 258, 7883-7886.
37. 2+/calmodulin-dependent protein kinase II with secretion and tyrosine hydroxylase activation in cultured bovine adrenal medullary cells. Mol. Pharmacol. 46, 1041-1047.
38. Vallee, R.B., Di Bartolomeis, M.J., Therkauf, W.E., 1981. A protein kinase bound to the projection portion of MAP-2: microtubule associated protein 2. J. Cell Biol. 90, 568-576.